| |
| |
|
| Insider
Information: |
Robertson Michelle |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
113,423 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$924,711 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
113,423 |
|
|
| Total
Value |
$924,711 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
10
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
9
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -272.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Chief Financial Officer |
2019-10-25 |
6,813 |
2019-02-12 |
0 |
Premium* |
|
|
Editas Medicine, Inc. |
EDIT |
|
2023-05-11 |
106,610 |
2020-01-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EDIT |
Editas Medicine, Inc. |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2023-05-11 |
4 |
S |
$9.87 |
$9,369 |
D/D |
(949) |
106,610 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2023-03-03 |
4 |
S |
$8.89 |
$1,636 |
D/D |
(184) |
107,559 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
31,500 |
107,743 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2023-02-13 |
4 |
S |
$9.67 |
$41,435 |
D/D |
(4,287) |
76,243 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2023-01-10 |
4 |
S |
$8.16 |
$14,296 |
D/D |
(1,752) |
80,530 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2022-12-05 |
4 |
S |
$10.23 |
$1,974 |
D/D |
(193) |
82,282 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2022-09-06 |
4 |
S |
$15.01 |
$2,882 |
D/D |
(192) |
82,475 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2022-06-03 |
4 |
S |
$11.54 |
$17,617 |
D/D |
(1,527) |
82,667 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2022-03-03 |
4 |
S |
$17.33 |
$13,290 |
D/D |
(767) |
84,194 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2022-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
53,499 |
84,961 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2022-01-11 |
4 |
S |
$25.70 |
$44,821 |
D/D |
(1,744) |
31,462 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2021-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,471 |
33,206 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2021-08-09 |
4 |
AS |
$60.00 |
$150,000 |
D/D |
(2,500) |
28,735 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2021-08-09 |
4 |
OE |
$30.65 |
$76,625 |
D/D |
2,500 |
31,235 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2021-06-28 |
4 |
AS |
$50.00 |
$125,000 |
D/D |
(2,500) |
28,735 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2021-06-28 |
4 |
OE |
$30.65 |
$76,625 |
D/D |
2,500 |
31,235 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2021-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,303 |
28,735 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2021-01-12 |
4 |
S |
$78.27 |
$122,727 |
D/D |
(1,568) |
18,432 |
0 |
% |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2020-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2019-10-25 |
4 |
AS |
$15.00 |
$102,030 |
D/D |
(6,802) |
6,813 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2019-10-18 |
4 |
AS |
$13.83 |
$40,605 |
D/D |
(2,936) |
13,615 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2019-10-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,750 |
16,551 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2019-04-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,725) |
6,801 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2019-02-14 |
4 |
AS |
$13.10 |
$9,209 |
D/D |
(703) |
11,526 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2019-02-13 |
4 |
AS |
$12.70 |
$17,907 |
D/D |
(1,410) |
12,229 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
